Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: yahoo finance guy doesn't get it...

TPL and our interest are different. I see it as we would like recurring revenue to attract investors. TPL wants the lump sum payments to finance their business interests. This Licensing portfolio can and probably will work to both our interest but unfortunately not right now.

JMHO

Share
New Message
Please login to post a reply